Overview
Fluticasone propionate is a synthetic glucocorticoid. These drugs are available as inhalers, nasal, sprays, and topical treatments for various inflammatory indications. Fluticasone propionate was first approved in 1990.
Indication
Fluticasone propionate is indicated as an inhaler for the treatment and management of asthma by prophylaxisas well as inflammatory and pruritic dermatoses. Fluticasone propionate nasal spray is indicated for managing allergic and nonallergic rhinitis.
Associated Conditions
- Allergic Rhinitis (AR)
- Allergy to Animal Dander
- Allergy to Mold
- Allergy to Tree Pollen
- Asthma
- Bacterial Sinusitis
- Chronic Bronchitis
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Sinusitis
- Dermatitis
- Emphysema
- Eosinophilic Esophagitis
- House Dust Mite Allergy
- House dust allergy
- Itching of the nose
- Nasal Congestion
- Non-Allergic Rhinitis
- Rhinitis
- Rhinitis Perennial
- Rhinorrhoea
- Seasonal Allergic Rhinitis
- Sneezing
- Moderate, severe Perennial Allergic Rhinitis (PAR)
- Moderate, severe Seasonal Allergic Rhinitis
Clinical Trials
View More Clinical Trials
Sign in to access the complete clinical trial database with detailed study information.
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2021/07/08 | Phase 4 | UNKNOWN | Xijing Hospital | ||
2021/05/13 | Phase 3 | Completed | Susanna Naggie, MD | ||
2021/02/11 | Phase 4 | Completed | |||
2020/12/21 | Phase 4 | Completed | |||
2020/12/19 | Phase 2 | Completed | |||
2020/12/17 | Phase 4 | Withdrawn | |||
2020/12/14 | Phase 3 | Completed | |||
2020/10/23 | Phase 4 | Withdrawn | |||
2020/09/25 | Phase 1 | Completed | |||
2020/09/11 | Phase 1 | Completed |
FDA Drug Approvals
View More FDA Approvals
Sign in to access additional FDA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. | 0168-0332 | TOPICAL | 0.5 mg in 1 g | 1/23/2019 | |
| Physicians Total Care, Inc. | 54868-5995 | RESPIRATORY (INHALATION) | 44 ug in 1 1 | 1/16/2012 | |
| GlaxoSmithKline LLC | 0173-0720 | RESPIRATORY (INHALATION) | 220 ug in 1 1 | 1/7/2019 | |
| Teva Respiratory, LLC | 59310-505 | RESPIRATORY (INHALATION) | 55 ug in 1 1 | 9/27/2022 | |
| Teva Pharmaceuticals USA, Inc. | 0093-7516 | RESPIRATORY (INHALATION) | 500 ug in 1 1 | 9/28/2022 | |
| Proficient Rx LP | 63187-638 | NASAL | 50 ug in 1 1 | 6/1/2022 | |
| Physicians Total Care, Inc. | 54868-5337 | TOPICAL | 0.5 mg in 1 g | 9/6/2011 | |
| Prasco Laboratories | 66993-088 | RESPIRATORY (INHALATION) | 230 ug in 1 1 | 8/1/2022 | |
| A-S Medication Solutions | 50090-3387 | RESPIRATORY (INHALATION) | 232 ug in 1 1 | 9/28/2022 | |
| NuCare Pharmaceuticals,Inc. | 68071-4156 | NASAL | 50 ug in 0.1 g | 2/15/2021 |
EMA Drug Approvals
View More EMA Approvals
Sign in to access additional EMA-approved drug information with detailed regulatory data.
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
View More HSA Approvals
Sign in to access additional HSA-approved drug information with detailed regulatory data.
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
View More NMPA Approvals
Sign in to access additional NMPA-approved drug information with detailed regulatory data.
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
View More PPB Approvals
Sign in to access additional PPB-approved drug information with detailed regulatory data.
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
View More TGA Approvals
Sign in to access additional TGA-approved drug information with detailed regulatory data.
Health Canada Drug Approvals
View More Health Canada Approvals
Sign in to access additional Health Canada approved drug information with detailed regulatory data.
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| PMS-FLUTICASONE | 02503174 | Powder - Inhalation | 500 MCG / ACT | N/A | |
| ARBESDA RESPICLICK | teva canada limited | 02474611 | Powder (Metered Dose) - Inhalation | 55 MCG / ACT | N/A |
| ALLERGY RELIEF NASAL SPRAY | 02460475 | Spray, Metered Dose - Nasal | 50 MCG / ACT | N/A | |
| FLOVENT HFA | 02244292 | Metered-Dose Aerosol - Inhalation
,
Oral | 125 MCG / ACT | 12/20/2001 | |
| CUTIVATE | 02089912 | Cream - Topical | 0.05 % | 11/8/2004 | |
| FLOVENT HFA | 02244291 | Metered-Dose Aerosol - Oral
,
Inhalation | 50 MCG / ACT | 12/20/2001 | |
| AERMONY RESPICLICK | teva canada limited | 02467895 | Powder (Metered Dose) - Inhalation | 55 MCG / ACT | 9/30/2020 |
| WIXELA INHUB | Mylan Pharmaceuticals ULC | 02495619 | Powder - Inhalation | 500 MCG / ACT | 2/13/2020 |
| WIXELA INHUB | Mylan Pharmaceuticals ULC | 02495597 | Powder - Inhalation | 100 MCG / ACT | 2/13/2020 |
| APO-FLUTICASONE HFA | 02528428 | Aerosol, Metered Dose - Inhalation
,
Oral | 50 MCG / ACT | 2/27/2025 |
CIMA AEMPS Drug Approvals
View More CIMA AEMPS Approvals
Sign in to access additional CIMA AEMPS approved drug information with detailed regulatory data.
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
View More Philippines FDA Approvals
Sign in to access additional Philippines FDA approved drug information with detailed regulatory data.
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
View More Saudi SFDA Approvals
Sign in to access additional Saudi SFDA approved drug information with detailed regulatory data.
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
View More Malaysia NPRA Approvals
Sign in to access additional Malaysia NPRA approved drug information with detailed regulatory data.
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
View More UK EMC Drug Information
Sign in to access additional UK EMC drug information with detailed pharmaceutical data.
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.